Kosugi, Japan

Kazuto Kunitani




Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Kosugi-machi, JP (2007)
  • Kosugi, JP (2010)

Company Filing History:


Years Active: 2007-2010

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuto Kunitani: Innovator in Antifungal Research

Introduction

Kazuto Kunitani is a notable inventor based in Kosugi, Japan. He has made significant contributions to the field of antifungal research, holding a total of 2 patents. His work focuses on developing innovative compounds that exhibit potent antifungal activity.

Latest Patents

Kunitani's latest patents include an arylamidine derivative and its salt, which demonstrate remarkable efficacy against fungi, including those resistant to azole-type drugs. The arylamidine derivative is represented by a specific general formula, where R denotes an optionally protected or substituted amidino group. These compounds have shown high safety profiles and excellent properties in repeated dose toxicity tests, making them valuable as antifungal agents. The derivatives possess good pharmacokinetics and pharmacodynamic properties, further enhancing their potential as effective treatments.

Career Highlights

Kazuto Kunitani is currently associated with Toyama Chemical Co., Ltd., where he continues to advance his research in antifungal agents. His work has been instrumental in developing new therapeutic options for fungal infections, which are a growing concern in medical science.

Collaborations

Kunitani collaborates with esteemed colleagues such as Kazuya Hayashi and Katsuji Ojima. Their combined expertise contributes to the innovative research and development of effective antifungal solutions.

Conclusion

Kazuto Kunitani's contributions to antifungal research highlight his role as a leading inventor in the field. His innovative compounds have the potential to significantly impact the treatment of fungal infections, showcasing the importance of continued research and development in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…